WaveMan
WaveMan · Company
GBCS · Selectis Health, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

GBCS Selectis Health (GBCS) Insider Trading, Ownership & Congress Trades

Real Estate · Real estate investment trusts · CIK 0000727346
Quote by TradingView
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter

Selectis Health insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for SELECTIS HEALTH, INC. in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
Desmond Adam
CEO
BUY
2026-03-23 SECtraded 2025-12-31
1,300
$2.9K
n/a
Context
  • 42 earlier Form 4 trades (code P or S) here by this insider (42 buys), the last on Dec 19, 2025.
  • +7.5% median (+12.1% mean) 90-day return after 19 previous buys.
  • The trade is 2.4% of the 53,069 shares held after it.
  • 1 other insider bought within 30 days.
Insider activity: CEO Desmond Adam bought about $2.9K of GBCS on Dec 31, 2025; 1 other insider bought within 30 days.
Desmond Adam
CEO
BUY
2026-03-12 SECtraded 2025-12-31
1,300
$2.9K
n/a
Context
  • 42 earlier Form 4 trades (code P or S) here by this insider (42 buys), the last on Dec 19, 2025.
  • +7.5% median (+12.1% mean) 90-day return after 19 previous buys.
  • The trade is 2.4% of the 53,069 shares held after it.
  • 1 other insider bought within 30 days.
Insider activity: CEO Desmond Adam bought about $2.9K of GBCS on Dec 31, 2025; 1 other insider bought within 30 days.
Desmond Adam
CEO
BUY
2026-03-23 SECtraded 2025-12-19
1,345
$3.0K
n/a
Context
  • 40 earlier Form 4 trades (code P or S) here by this insider (40 buys), the last on Oct 17, 2025.
  • +6.8% median (+8.1% mean) 90-day return after 18 previous buys.
  • The trade is 2.6% of the 51,769 shares held after it.
  • 1 other insider bought within 30 days.
Insider activity: CEO Desmond Adam bought about $3.0K of GBCS on Dec 19, 2025; 1 other insider bought within 30 days.
Desmond Adam
CEO
BUY
2026-03-12 SECtraded 2025-12-19
1,345
$3.0K
n/a
Context
  • 40 earlier Form 4 trades (code P or S) here by this insider (40 buys), the last on Oct 17, 2025.
  • +6.8% median (+8.1% mean) 90-day return after 18 previous buys.
  • The trade is 2.6% of the 51,769 shares held after it.
  • 1 other insider bought within 30 days.
Insider activity: CEO Desmond Adam bought about $3.0K of GBCS on Dec 19, 2025; 1 other insider bought within 30 days.
Baller Lance
Director
BUY
2026-01-14 SECtraded 2025-12-18
6,192
$13.6K
n/a
Context
  • 2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on Oct 6, 2022.
  • The trade is 11.7% of the 52,808 shares held after it.
  • 1 other insider bought within 30 days.
Insider activity: Director Baller Lance bought about $13.6K of GBCS on Dec 18, 2025, the largest insider purchase at the company since 2021; 1 other insider bought within 30 days.
50 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 45 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
+4.9% year over year
more than 52% of Real Estate
Margin
-2.5% net margin
below 68% of Real Estate
Buybacks
no share repurchases reported
Short interest
no short interest reported
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch GBCS

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+237.1%12M
-12%+73%+158%+243%2025-102025-122026-022026-042026-062026-082026-09 2025-12-18 · Baller Lance bought $13.6K2025-12-19 · Desmond Adam bought $3.0K2025-12-19 · Desmond Adam bought $3.0K2025-12-31 · Desmond Adam bought $2.9K2025-12-31 · Desmond Adam bought $2.9K
Insider buy
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns GBCS: institutional holders (13F)

13F holdings, latest reported quarter
SEC 13F
No reported 13F holders

No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.

Congress trades in GBCS

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

GBCS planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
Each figure here is a federal filing, dated the day it went public, so you can test what was knowable then.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
EQIXBRTACRFPHIRMNYCSPGOPENMDVMDRRAATAXR

GBCS financials

Revenue growth
+4.9%
XBRL, annual
Net margin
-2.5%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$32.5M
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
+44.9%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
-$3.9M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
2.13x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Cash flow to debt
-0.20x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Return on equity
+2,484%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
+44.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
tax provision or pre-tax income not filed for the four quarters
Return on capital employed
-25.3%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
1.35x
close 2026-10-06 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
Enterprise value
$26.8M
market value at close 2026-10-06 on 2026-08-21 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
FCF yield
-22.0%
TTM free cash flow over market value at close 2026-10-06
PEG, trailing
n/a
prior-year trailing EPS was a loss, growth undefined
Price as of 2026-10-06. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$41.4M$39.5M$36.8M$40.6M
Operating income-$1.6M-$2.7M-$9.0M-$286.6K
Net income-$1.0M-$2.4M-$4.0M-$2.4M
EPS (diluted)-0.34-0.80-1.31-0.79
Operating cash flow$1.9M-$1.8M$536.7K-$305.1K
Cash$1.0M$680.3K$1.5M$1.4M
Long-term debt$13.4M$19.1M$25.2M$34.4M
SEC XBRL, fiscal years, as known on 2026-10-28

GBCS Stock Sonar score 4/7 axes

Find similar shapesCompare

GBCS ranks highest on profitability (72nd percentile) and risk and compliance (62nd), and lowest on financial health (14th), among Real Estate peers.

Profitability
72
Inputs
  • Return on equity+2484% · 100 pct, sector of 230
  • Return on assets+44.9% · 100 pct, sector of 255
  • Return on invested capitaltax provision or pre-tax income not filed for the four quarters
  • Return on capital employed-25.3% · 15 pct, sector of 47
Financial health
14
Inputs
  • Debt to equity2.13x · 23 pct, sector of 210
  • Cash flow to debt-0.20x · 5 pct, sector of 215
Growth
53
Inputs
  • Revenue growth, YoY+4.9% · 53 pct, sector of 244
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Risk and compliance
62
Inputs
  • Short interest, % of floatno short interest or no free float on file
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-K+6.6% · 62 pct, sector of 212
3 not measured: Insider conviction, Institutional and government, US patents
  • Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
  • Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies